News
Vinay Prasad is returning to his role at the U.S. Food and Drug Administration, a little more than a week after he had left ...
2hon MSN
Vinay Prasad is returning to his role at the U.S. Food and Drug Administration to resume overseeing vaccine, gene therapy and ...
1d
MedPage Today on MSNFDA Restricts Gene Therapy Skysona Due to Blood Cancer RiskThe FDA approved labeling changes for elivaldogene autotemcel (eli-cel; Skysona), a one-time gene therapy for patients with ...
Vinay Prasad is returning to his role overseeing vaccine, gene therapy and blood product regulation at the U.S. Food and Drug ...
After a strong launch for its cancer gene therapy, Ferring Pharmaceuticals is setting the stage for long-term growth.
Vinay Prasad, M.D., has rejoined the FDA, the latest turn in a monthslong stretch of leadership turnover at the agency. | “At ...
Currently, GenAns Biotech is conducting investigator-initiated trials for several gene therapies, including GA001 for ...
WASHINGTON — Vinay Prasad is returning to the Food and Drug Administration to resume his role overseeing vaccine, gene ...
US Food and Drug Administration Commissioner Marty Makary said he’s trying to persuade Vinay Prasad, the agency’s former head ...
CGT Global, a leading biotechnology company driving the development and delivery of innovative cell and gene therapies, today ...
Sarepta Therapeutics (SRPT) stock in focus as report says company hired a Trump-linked lobbying firm after deaths linked to ...
Ocugen says it is on track to reshape the market for gene therapies against eye disorders over the next three years, by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results